Definitive Healthcare (DH) vs eGain (EGAN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
eGain (EGAN) has outperformed Definitive Healthcare (DH) over the past year, losing 47.5% versus a loss of 56.5%. Over five years, EGAN leads with a -43.9% price change compared with -96.0% for DH. eGain is the larger company by market cap ($141.0 million vs $128.6 million), about 1.1 times the size.
eGain converts more of its revenue into profit, with a net margin of 9.7% versus -57.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DH | EGAN |
|---|---|---|
| Share price | $1.20 | $5.59 |
| Market cap | $128.60M | $140.99M |
| 1-day change | -0.83% | -3.62% |
| YTD return | -58.19% | -45.68% |
| 1-year return | -56.52% | -47.46% |
| 5-year return | -95.99% | -43.93% |
| P/E ratio (TTM) | — | 19.96 |
| Forward P/E | 6.45 | — |
| EPS (TTM) | $-1.50 | $0.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $241.52M | $91.14M |
| Revenue growth (YoY) | -4.24% | +3.06% |
| Net income (latest FY) | $-138.93M | $8.88M |
| Gross margin | 75.88% | 73.35% |
| Operating margin | -92.86% | 8.74% |
| Net margin | -57.52% | 9.74% |
| 52-week high | $3.00 | $11.52 |
| 52-week low | $0.61 | $5.02 |
| Distance from 52-week high | -60.00% | -51.48% |
| Analyst consensus | hold | none |
| Avg. price target upside | +35.83% | +13.24% |
| Average volume | 682.42K | 245.81K |
| Shares outstanding | 107.16M | 25.22M |
| Employees | 678 | 420 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- eGain is more profitable, keeping 9.7 cents of every revenue dollar as net income versus -57.5 cents for Definitive Healthcare.
- eGain grew revenue faster in its latest fiscal year (+3.06% vs -4.24%).
About Definitive Healthcare
DH stock →Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Technology · Computer Software: Prepackaged Software · 678 employees
About eGain
EGAN stock →eGain Corporation engages in the development, license, implementation, and support of AI-powered knowledge management and customer experience automation solutions for enterprises in North America, Europe, the Middle East, and Africa. The company offers eGain AI Agent, which helps businesses to deploy enterprise-grade agentic solutions built on knowledge and guided actions; eGain AI Knowledge Hub to centralize knowledge, policies, procedures, situations, and best-practices, as well as guided and personalized answers to customers, agents, and field staff; and eGain Conversation Hub for scalable capabilities of digital-first interaction management within a modern, omnichannel desktop.
Technology · Computer Software: Prepackaged Software · 420 employees
DH vs EGAN FAQ
Which is bigger, Definitive Healthcare or eGain?
eGain (EGAN) is larger, with a market capitalization of $140.99M compared with $128.60M for Definitive Healthcare (DH).
Which stock has performed better over the past year, DH or EGAN?
EGAN returned -47.46% over the past 12 months, compared with -56.52% for DH (price return, excluding dividends). Past performance does not predict future results.
Are Definitive Healthcare and eGain in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.